Skip to content

Internet-based Group Contingency Management to Promote Smoking Abstinence

Internet-based Group Contingency Management to Promote Smoking Abstinence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01181661
Enrollment
40
Registered
2010-08-13
Start date
2010-08-31
Completion date
2013-08-31
Last updated
2014-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

Cigarette, Smoking, Nicotine, Contingency Management, Voucher Reinforcement, Smoking Abstinence, Internet, Internet-based Treatment, Group Contingencies

Brief summary

The purpose of the study is to develop and test an Internet-based group contingency management program designed to promote smoking cessation.

Interventions

BEHAVIORALFull Group Contingency

This group (n = 20) will earn vouchers based only on team (n = 4) performance. Only if all members of the team submit a negative sample (CO ≤ 4 ppm), will they each earn a voucher.

BEHAVIORALMixed Group Contingency

This group (n = 20) will earn vouchers based on both individual and team (n = 4) performance. If an individual submits a negative sample (CO ≤ 4 ppm), s/he will earn a voucher. Additionally, bonus vouchers will be earned if all team members submit negative samples.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
National Development and Research Institutes, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* self-reported smoker * ability to use the Internet * permission to contact applicant by phone

Exclusion criteria

* self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study * inability to avoid high levels of ambient CO (e.g., occupational exposure; lives with a another smoker who smokes in the home)

Design outcomes

Primary

MeasureTime frameDescription
Breath CO8 weeksTwice daily breath CO samples obtained during baseline and treatment

Secondary

MeasureTime frameDescription
Point prevalence measure of abstinenceat the end of treatment (approximately week 4) and at 3 month follow-upAbstinence will be defined as: (a) CO sample ≤ 4 ppm; (b) cotinine \< 50 ng/ml; and (c) reporting not smoking, not even a puff in the last 7 days.
Duration of abstinence during treatment.3 weeksThe longest duration of sustained abstinence (CO ≤ 4 ppm) based on the twice-daily breath samples during the treatment period.
Rate of social exchanges3 weeksThe number of comments posted on the discussion forum during treatment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026